The Third Affiliated Hospital of Xinxiang Medical university

Xinxiang, Henan 453003

1 studies enrolling now · 4 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Age Related Macular Degeneration, High-risk Transient Ischemic Attack, Metastatic Castration-Resistant Prostate Cancer, NASH - Nonalcoholic Steatohepatitis, Prevention of Ischemic Stroke

Studies at this site

• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. — Recruiting now
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD — Completed